Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
0.5767
-0.0033 (-0.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
33
34
Next >
Mid-Morning Market Update: Markets Open Lower; U.S. Economy Adds 678,000 Jobs
March 04, 2022
U.S. stocks opened on a downbeat note this morning following the release of weekly jobless claims data. Following the market opening Friday, the Dow traded down 1.29% to 33,360.18...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 04, 2022
Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo...
Via
Benzinga
FDA Denies Pediatric EUA To Ocugen For Bharat Biotech's COVID-19 Vaccine Covaxin
March 04, 2022
The FDA has declined to issue an Emergency Use Authorization (EUA) for Covaxin for active immunization to prevent COVID-19 in individuals 2 to 18 years of age. Ocugen...
Via
Benzinga
Why Ocugen Shares Are Falling
March 04, 2022
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8%...
Via
Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In...
Via
Benzinga
Recap: Ocugen Q4 Earnings
February 25, 2022
Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Also check...
Via
Benzinga
Why Ocugen Shares Are Falling
February 23, 2022
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 19.6%...
Via
Benzinga
Looking Into Ocugen Inc's Recent Short Interest
March 02, 2022
Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 8.35% since its last report. The company recently reported that it has 54.94 million shares sold short, which is 30.23...
Via
Benzinga
Earnings Scheduled For February 25, 2022
February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...
Via
Benzinga
63 Biggest Movers From Yesterday
February 24, 2022
Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a...
Via
Benzinga
Is OCGN Stock a Buy After 20% Plunge? One Analyst Thinks It Can Go to $15.
February 23, 2022
Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock?
Via
InvestorPlace
7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio
February 23, 2022
These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold.
Via
InvestorPlace
40 Stocks Moving In Wednesday's Mid-Day Session
February 23, 2022
Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share...
Via
Benzinga
Vertiv News: Why Is VRT Stock Plunging Today?
February 23, 2022
Vertiv (VRT) stock isn't doing so hot on Wednesday following the release of the manufacturing company's earnings report for Q4 2021.
Via
InvestorPlace
OCGN Stock Alert: The $50 Million Reason Ocugen Is Tanking Today
February 23, 2022
After rising sharply in recent days, Ocugen shares are again falling on news that the company is issuing $50 million of common stock.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 23, 2022
Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at...
Via
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
February 23, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...
Via
Benzinga
73 Biggest Movers From Yesterday
February 23, 2022
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 22, 2022
Gainers Revelation Biosciences (NASDAQ:REVB
Via
Benzinga
Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval
February 22, 2022
Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point.
Via
InvestorPlace
Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher
February 22, 2022
U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led...
Via
Benzinga
Production Updates Could Give Novavax Stock a Big Boost
February 22, 2022
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 22, 2022
Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,...
Via
Benzinga
Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points
February 22, 2022
U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would...
Via
Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
February 22, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...
Via
Benzinga
Dow Drops Triple Digits as Investors Eye Sanctions
February 22, 2022
The Dow Jones Industrial Average is down 292 points midday. The S&P 500 Index and Nasdaq Composite are sharply lower as well, as the major indexes begin their holiday-shortened week after their...
Via
Talk Markets
Dear AMC Stock Fans, Mark Your Calendars for March 1
February 22, 2022
Investors in AMC Entertainment (AMC) stock are going to want to keep an eye on the movie theater company when March 1 rolls around.
Via
InvestorPlace
Chinese Stocks Alert: Why Are BABA, TCEHY, JD, PDD Stocks Down Today?
February 22, 2022
Chinese tech stocks are taking a beating on Tuesday as investors worry about additional restrictions from the country's government.
Via
InvestorPlace
Why Ocugen Shares Are Rising
February 22, 2022
Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 23.8% at $4.28 Tuesday morning after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.